Robert Vaters Insider Profile

4 Followers
Robert Vaters, President & CFO, Director at Lisata Therapeutics, holds 228.75K shares in Lisata Therapeutics (Ticker: LSTA), holds 65.62K shares in Orthofix (Ticker: OFIX). Most recently, Robert Vaters Bought ― shares of Lisata Therapeutics on Aug 13, 2015 for an estimated value of 16.60K.
tipranks
Robert Vaters

Robert Vaters
Lisata Therapeutics (LSTA)
President & CFO, Director

Ranked #84,572 out of 99,218 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-56.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
65.67%
34.33%
A breakdown of Robert Vaters's holdings

Insider Roles

Orthofix
(OFIX)
President & CEO
Lisata Therapeutics
(LSTA)
President & CFO, Director
Roles that Robert Vaters holds in companies

Most Profitable Insider Trade

Stock:
Lisata Therapeutics
(LSTA)
Rating:Informative Buy
Date:Aug 11, 2015 - Aug 11, 2016
Return:-54.60%
The most profitable trade made by Robert Vaters

Robert Vaters's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Lisata Therapeutics
Aug 13, 2015
President & CFO, Director
Informative Buy
16.60K
$665.66K
Orthofix
Feb 27, 2013
President & CEO
Informative Buy
107.91K
$1.27M
List of latest transactions for each holding click on a transaction to see Robert Vaters's performance on stock

Robert Vaters insider profile FAQ

What is the percentage of profitable transactions made by Robert Vaters?
The percentage of profitable transactions made by Robert Vaters is 0%.
    What is the average return per transaction made by Robert Vaters?
    The average return per transaction made by Robert Vaters is -56.80%.
      What stocks does Robert Vaters hold?
      Robert Vaters holds: LSTA, OFIX stocks.
        What was Robert Vaters’s latest transaction?
        Robert Vaters latest transaction was an Informative Buy of $16.60K.
          What was Robert Vaters's most profitable transaction?
          Robert Vaters’s most profitable transaction was an Informative Buy of LSTA stock on August 11, 2015. The return on the trade was -54.60%.
            What is Robert Vaters's role in Lisata Therapeutics?
            Robert Vaters's role in Lisata Therapeutics is President & CFO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.